ClinVar Miner

Submissions for variant NM_170707.4(LMNA):c.1156A>G (p.Arg386Gly)

dbSNP: rs1572363397
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000801706 SCV000941498 pathogenic Charcot-Marie-Tooth disease type 2 2021-05-17 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been reported to affect LMNA protein function (PMID: 23427149). This variant has been observed to be de novo in an individual affected with muscular dystrophy (Invitae). This sequence change replaces arginine with glycine at codon 386 of the LMNA protein (p.Arg386Gly). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and glycine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.